跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RASAGILINE-TEVA rasagiline (as mesilate) 1 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
RASAGILINE-TEVA rasagiline (as mesilate) 1 mg tablet blister pack
Approved
STANDARD
RASAGILINE-TEVA rasagiline (as mesilate) 1 mg tablet blister pack
Teva Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
7dcf41b774f71f92
Company
Teva Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
7dcf41b774f71f92
Product Name
RASAGILINE-TEVA rasagiline (as mesilate) 1 mg tablet blister pack
Artg Id
294880
Artg Name
RASAGILINE-TEVA rasagiline (as mesilate) 1 mg tablet blister pack
Sponsor
Teva Pharma Australia Pty Ltd
Company Detail Path
/organization/teva-pharma-australia-pty-ltd
Artg Date
2017-12-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d5b7d25f6960502895df5396ad6c6888.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/72d3e86c24af4d00544e3d68a187ef32.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
7dcf41b774f71f92
Type
Standard
Back to TGA Approvals